Syndevrx
Financial Services · Biotechnology
Facts
as of Nov 17, 2026About Company Our Team Investor Science Metabo-oncology Drug Conjugation Angiogenesis Pipeline Clinical trials Patients Media SynDevRx Publications Press Releases and Events Other Related Contact us About Us About SynDevRx We are dedicated to making Metabo-Oncology a new cancer treatment modality.
- Legal name
- SYNDEVRX INC
- Headquarters
- Cambridge, United States
- Founded
- 1992
- Employees
- 51-200estimated range
- Register numbers
- NAME syndevrx inc
- Official records
- SEC CIK 1455364
- Website
- syndevrx.com
These are the key facts about Syndevrx on Alion as of Nov 17, 2026. Syndevrx is headquartered in Cambridge, United States. It was founded in 1992.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
SYNDEVRX INC
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Cambridge United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$79.2MTotal raised
Debt FinancingLatest round
8Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
$29.4M
2020
$23.2M
2012
$16.3M
2024
$6.5M
2017
$1.5M
Sources: funding announcements, grant and company registers
Milestones
Nov 4, 2024
Took on debt financing $6.5M · SEC Form D
Sep 30, 2024
Raised a round Venture round $29.4M · SEC Form D
1992
Founded
Each milestone is dated by its source: registers, filings, the press
